#USA #Toronto #Avid Bioservices #Monoclonal Antibodies #Xtalks

Improving Monoclonal Antibody Manufacturing

In recent years, monoclonal antibodies (mAbs) have emerged as essential components in the treatment of various diseases such as cancers, autoimmune disorders, and infectious diseases. As demand increases, so does the necessity for efficient and scalable production practices. To support the industry in maximizing its production capabilities, Xtalks is hosting a free webinar focusing on the critical elements of mAb manufacturing.

Webinar Focus

The webinar, titled Improve Biologic Modalities Manufacturing for mAb Readiness, will feature expert insights on optimizing the development processes for mAbs. Attendees will benefit from a comprehensive overview of both upstream and downstream development strategies. Key topics include:

• - Cell Line Development: Understanding the right selection and engineering processes that influence the yield and quality of mAbs.
• - Process Optimization: Techniques for improving production processes, ensuring they are robust and reliable.
• - Purification Strategies: Common practices, such as Protein A chromatography, that effectively remove impurities while preserving product integrity.

Best Practices for mAb Production

Even though mAbs are often regarded as predictable biologic products, developing them successfully still requires meticulous planning. From the initial stages of cell line selection to the final purification processes, maintaining product quality and manufacturing readiness is imperative.

The expert speaker, Dave Briggs, PhD, a Principal Scientist from Avid Bioservices, will guide participants through core manufacturing considerations, emphasizing:

• - Analytical Characterization: The analytical tools necessary to assure product quality during the manufacturing stages.
• - Process Robustness: Importance of sustaining quality throughout the production lifecycle, leading to a reliable commercial supply.
• - Scale-Up Planning: Strategies to efficiently transition from small-scale to large-scale production without loss of quality.

Why Attend the Webinar?

For professionals in biotech, pharmaceutical, and medtech industries, this is a unique opportunity to gain knowledge on effective monoclonal antibody manufacturing protocols. Understanding these essential practices allows organizations to enhance efficiency while ensuring compliance with regulatory requirements.

Furthermore, partnerships with experienced Contract Development and Manufacturing Organizations (CDMOs) can greatly enhance technology transfer, validation, and ultimately, commercialization efforts.

Event Details

The live webinar will take place on Tuesday, August 18, 2026, at 12 PM EDT (6 PM CEST). To register for this insightful session, visit the official Xtalks page. Don’t miss the chance to learn from industry leaders and optimize your mAb production processes!

About Avid Bioservices

Avid Bioservices is recognized as a premier U.S.-based CDMO specializing in mammalian cell culture. With a proven track record in integrated process development and commercial supply, Avid is committed to guiding molecules from DNA to IND through to market. For more information about their services, feel free to check out their website at www.avidbio.com.

Join the Conversation

The life science community continues to thrive, driven by collaborative efforts and shared knowledge. Xtalks serves as a platform providing valuable insights through news articles, podcasts, and webinars designed to meet the evolving needs of the industry professionals. Visit www.xtalks.com for more information on webinars and events tailored to your interests.

Don’t miss out on this chance to enhance your knowledge and skills in monoclonal antibody manufacturing—register today!